Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6005 USD | +11.78% | +20.03% | -57.41% |
04-01 | BTIG Research Downgrades P3 Health Partners to Neutral From Buy | MT |
03-28 | Transcript : P3 Health Partners Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.41% | 64.15M | |
+0.32% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.76% | 24.63B | |
-23.32% | 18.2B | |
+27.79% | 12.01B | |
-2.35% | 11.76B | |
+14.21% | 10.4B | |
-4.90% | 9.94B |
- Stock Market
- Equities
- PIII Stock
- News P3 Health Partners Inc.
- P3 Health Partners Appoints Atul Kavthekar Chief Financial Officer